摘要:
The invention is concerned with a transdermal therapeutic system (TTS) comprising fentanyl and a method of manufacturing such a TTS. The transdermal therapeutic system is used for the transdermal administration of fentanyl and analogues thereof. In particular, the invention relates to the use of a transdermal therapeutic system (TTS) for analgesic purposes. The TTS according to the invention comprises a drug containing adhesive composition comprising fentanyl, a styrenic polymer, a liquid diluent, a penetration enhancer and optionally a tackifier.
摘要:
The invention relates to highly stable aqueous G-CSF-containing compositions that contain succinate and/or tartrate as the buffer substance. The invention also relates to lyophilisates and powders that are obtainable from the aforementioned compositions and to drug kits containing such lyophilisates and powders.
摘要:
The invention relates to a film-shaped, single-layered and cavity-free preparation that does not contain any surfactants nor effervescent additives and flavor masking agents, comprised of film forming agents, one or more gelling agents and of one or more active substances selected from the group of neuroleptic drugs.
摘要:
The invention relates to a method for producing an oxaliplatin aqueous solution consisting in diluting oxaliplatin by adding an acid in such a way that the oxaliplatin concentration greater than the concentration of the acid-free oxaliplatin aqueous solution is obtained. A container and a container set containing the inventive solution are also disclosed.
摘要:
The invention relates to a film-shaped, single-layered and cavity-free preparation that does not contain any surfactants nor effervescent additives and flavor masking agents, comprised of film forming agents, one or more gelling agents and of one or more active substances selected from the group of antiemetics and antimigraine agents.
摘要:
The invention relates to a wet granulator (1) with a granulating liquid supply (3). The granulator (1) comprises a container (4), having a bottom part (5) and a head part (6). The container (4) comprises an input opening (7) for supplying said bottom part (5) with powder and/or particles to be granulated with the aid of said granulating liquid (2) and an output opening (8) to exit the produced granulates. The bottom part (5) comprises a multi blade impeller (9) driven by a drive motor (10) beneath the container (4) or driven by a shaft extending through said head part (6) with a drive motor on top of said container (4). An auxiliary chopper (11) is positioned above said impeller (9). The granulating liquid supply (3) comprises an irrigation nozzle (12), which is positioned in said head part (6) inside said container (4) and comprises a nozzle plate (13) having a plurality of through holes (17) providing liquid beams (18) of granulating liquid (12) directed toward said bottom part (5) of said container (4).
摘要:
The invention relates to a method for the solvent-free production of a homogenised product, especially for implants or microparticles, whereby at least one polymer and at least one active ingredient in the form of raw materials are homogenised at the glass transition temperature of the polymer(s), and are brought to room temperature following homogenisation.
摘要:
Die Erfindung beschreibt ein Behältnis (1) zur Separation von Tumorzellen, insbesondere disseminierten Tumorzellen (9), von einer biologischen Probe mit einem geschlossenen und einem öffenbaren Ende (2, 3). Eine thixotrope Substanz (4) ist mit einer spezifischen Dichte ausgewählt aus einem Bereich mit einer unteren Grenze von 1,055 g/cm3, vorzugsweise 1,057 g/cm3, insbesondere 1,060 g/cm3, und einer oberen Grenze von 1,070 g/cm3, vorzugsweise 1,069 g/cm3, insbesondere 1,065 g/cm3, und gegebenenfalls ein Separationsmedium (5) in Form eines Dichtegradienten mit einer spezifischen Dichte ausgewählt aus einem Bereich mit einer unteren Grenze von 1,060 g/cm3, vorzugsweise 1,065 g/cm3, insbesondere 1,070 g/cm3, und einer oberen Grenze von 1,085 g/cm3, vorzugsweise 1,080 g/cm3, insbesondere 1,075 g/cm3, enthalten.
摘要翻译:触变物质(4)的比密度为1.06〜1.065g / cm 3,分离介质(5)的比密度为1.070〜1.075g / cm 3。 触变物质是硅酸,膨润土,锂蒙脱石,高岭土,藻酸盐或它们的混合物。 分离介质是水溶液,是硅酸盐聚合物,糖类或泛影酸盐,例如 Percoll(RTM:用聚乙烯吡咯烷酮涂覆的胶体二氧化硅颗粒)和Ficoll(RTM:多糖)。 介质和触变物质含有染料。 多孔屏障(6):由疏水材料组成; 和/或配备疏水涂层; 由弹性体界定; 配有捕捉元素; 厚度为2-5毫米; 孔径为20-50μm,由膜,薄片,玻璃料和/或过滤器形成。 独立权利要求包括:(1)识别传播肿瘤细胞的程序; (2)生物样品和离子分离介质的比重密度排列; 和(3)试剂盒。
摘要:
The invention relates to a transdermal system containing fentanyl as an active ingredient and consisting of, or comprising, a substrate, a mixture which is applied to the substrate and consists of the active ingredient, an oleaginous Aloe vera extract, a resin and a bonding agent, in addition to a layer which covers the mixture applied to the substrate.
摘要:
The invention relates to a cover layer which is impermeable to active substances and /or a removable protective layer of a transdermal therapeutic system, these layers consisting of a thermoplastic film and containing either absorption agents and channel forming agents directly or being coated with a polymer support (thermoplastic) containing these substances. Said polymer support can be applied directly during production, either over the entire film or in patterns. The thermoplastic film that is used and the polymer support can consist of identical or different materials.